Eiger BioPharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Nanobac Pharmaceuticals, Incorporated
|
- USD
|
-Infinity%
|
SQZ Biotechnologies Company
|
20.9 Million USD
|
95.814%
|
Evofem Biosciences, Inc.
|
8000.00 USD
|
-10840.0%
|
Santhera Pharmaceuticals Holding AG
|
1.75 Million USD
|
50.145%
|
Mesoblast Limited
|
100.29 Million USD
|
99.127%
|
Propanc Biopharma, Inc.
|
58.64 Thousand USD
|
-1392.446%
|
Genus plc
|
228.2 Million USD
|
99.616%
|
VioQuest Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
CNBX Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
Marizyme, Inc.
|
667.12 Thousand USD
|
-31.189%
|
ContraFect Corporation
|
2.21 Million USD
|
60.398%
|
Nymox Pharmaceutical Corporation
|
- USD
|
-Infinity%
|
PsyBio Therapeutics Corp.
|
- USD
|
-Infinity%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
1.4 Million USD
|
37.616%
|
Intellipharmaceutics International Inc.
|
- USD
|
-Infinity%
|
AXIM Biotechnologies, Inc.
|
5.42 Million USD
|
83.872%
|
MultiCell Technologies, Inc.
|
36.43 USD
|
-2402315.592%
|
Accustem Sciences Inc.
|
- USD
|
-Infinity%
|
RVL Pharmaceuticals plc
|
55.61 Million USD
|
98.426%
|
EV Biologics, Inc.
|
- USD
|
-Infinity%
|
Q BioMed Inc.
|
- USD
|
-Infinity%
|
Emmaus Life Sciences, Inc.
|
2.22 Million USD
|
60.683%
|
Neon Bloom, Inc.
|
- USD
|
-Infinity%
|
Mosaic ImmunoEngineering Inc.
|
1.22 Million USD
|
28.751%
|
Biomind Labs Inc.
|
- USD
|
-Infinity%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
-Infinity%
|
Pharming Group N.V.
|
166.1 Million USD
|
99.473%
|
Oncotelic Therapeutics, Inc.
|
1.89 Million USD
|
53.9%
|
Skye Bioscience, Inc.
|
171.23 Thousand USD
|
-411.125%
|
Therapeutic Solutions International, Inc.
|
5512.00 USD
|
-15778.084%
|
THC Farmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Arch Therapeutics, Inc.
|
- USD
|
-Infinity%
|
IMV Inc.
|
27.39 Million USD
|
96.806%
|
Acro Biomedical Co., Ltd.
|
- USD
|
-Infinity%
|
Curative Biotechnology, Inc.
|
- USD
|
-Infinity%
|
GB Sciences, Inc.
|
322 Thousand USD
|
-171.801%
|
Alpha Cognition Inc.
|
- USD
|
-Infinity%
|
HST Global, Inc.
|
- USD
|
-Infinity%
|
CSL Limited
|
11.23 Billion USD
|
99.992%
|
Halberd Corporation
|
150 Thousand USD
|
-483.467%
|
Enzolytics Inc.
|
- USD
|
-Infinity%
|
Resverlogix Corp.
|
- USD
|
-Infinity%
|
Affymax, Inc.
|
- USD
|
-Infinity%
|
SYBLEU INC
|
300 Thousand USD
|
-191.733%
|
Nuo Therapeutics, Inc.
|
164.2 Thousand USD
|
-432.992%
|
argenx SE
|
15.35 Million USD
|
94.3%
|
MetaStat, Inc.
|
- USD
|
-Infinity%
|
Northwest Biotherapeutics, Inc.
|
20.31 Million USD
|
95.691%
|
Enzon Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Arno Therapeutics, Inc.
|
- USD
|
-Infinity%
|
RespireRx Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
GeneThera, Inc.
|
- USD
|
-Infinity%
|
Inhibitor Therapeutics, Inc.
|
- USD
|
-Infinity%
|
AVAX Technologies, Inc.
|
- USD
|
-Infinity%
|
Zenith Capital Corp.
|
4456.00 USD
|
-19540.934%
|
Genscript Biotech Corporation
|
287.12 Million USD
|
99.695%
|
Ember Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Sigyn Therapeutics, Inc.
|
126.3 Thousand USD
|
-592.942%
|
WPD Pharmaceuticals Inc.
|
229.29 Thousand USD
|
-281.698%
|
American Oriental Bioengineering, Inc.
|
554.59 Thousand USD
|
-57.81%
|
Provectus Biopharmaceuticals, Inc.
|
25.29 Thousand USD
|
-3359.425%
|
Adynxx, Inc.
|
- USD
|
-Infinity%
|
Helix BioMedix, Inc.
|
- USD
|
-Infinity%
|
GlobeStar Therapeutics Corporation
|
- USD
|
-Infinity%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
-Infinity%
|
Capstone Therapeutics Corp.
|
8.26 Million USD
|
89.409%
|
Cotinga Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
BioStem Technologies, Inc.
|
265.63 Thousand USD
|
-229.475%
|
ONE Bio Corp.
|
592.19 Thousand USD
|
-47.788%
|
Reve Technologies, Inc.
|
1064.00 USD
|
-82155.639%
|
Burzynski Research Institute, Inc.
|
- USD
|
-Infinity%
|
Wesana Health Holdings Inc.
|
- USD
|
-Infinity%
|
Agentix Corp.
|
- USD
|
-Infinity%
|
LadRx Corporation
|
- USD
|
-Infinity%
|
Cell Source, Inc.
|
- USD
|
-Infinity%
|
ProtoKinetix, Incorporated
|
- USD
|
-Infinity%
|
Regen BioPharma, Inc.
|
149.61 Thousand USD
|
-484.972%
|
Regen BioPharma, Inc.
|
149.61 Thousand USD
|
-484.972%
|
NovAccess Global Inc.
|
- USD
|
-Infinity%
|
Endonovo Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Itoco Inc.
|
- USD
|
-Infinity%
|
Rasna Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Pathfinder Cell Therapy, Inc.
|
- USD
|
-Infinity%
|
Kadimastem Ltd
|
229.69 Thousand USD
|
-281.034%
|
Oncology Pharma Inc.
|
- USD
|
-Infinity%
|
Institute of Biomedical Research Corp.
|
- USD
|
-Infinity%
|
CytoDyn Inc.
|
141 Thousand USD
|
-520.709%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
NDT Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
Mobile Lads Corp.
|
- USD
|
-Infinity%
|
NanoSphere Health Sciences Inc.
|
- USD
|
-Infinity%
|
Qrons Inc.
|
80 Thousand USD
|
-994.0%
|
Alseres Pharmaceuticals, Inc.
|
7.81 Million USD
|
88.808%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
-Infinity%
|
Nascent Biotech, Inc.
|
- USD
|
-Infinity%
|
Rebus Holdings, Inc.
|
- USD
|
-Infinity%
|
ImmunoCellular Therapeutics, Ltd.
|
369.04 Thousand USD
|
-137.15%
|
International Stem Cell Corporation
|
445 Thousand USD
|
-96.674%
|
Bioxytran, Inc.
|
- USD
|
-Infinity%
|
GlobeImmune, Inc.
|
- USD
|
-Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
-Infinity%
|
ProText Mobility, Inc.
|
- USD
|
-Infinity%
|
Cardax, Inc.
|
- USD
|
-Infinity%
|
VG Life Sciences Inc.
|
- USD
|
-Infinity%
|
Kaleido Biosciences, Inc.
|
- USD
|
-Infinity%
|
Advaxis, Inc.
|
8.15 Million USD
|
89.261%
|
Adhera Therapeutics, Inc.
|
- USD
|
-Infinity%
|
RenovaCare, Inc.
|
- USD
|
-Infinity%
|
Regnum Corp.
|
- USD
|
-Infinity%
|
Innovation Pharmaceuticals Inc.
|
457 Thousand USD
|
-91.51%
|
Neutra Corp.
|
- USD
|
-Infinity%
|
Windtree Therapeutics, Inc.
|
1.16 Million USD
|
24.617%
|
PureTech Health plc
|
18.25 Million USD
|
95.204%
|
Coeptis Therapeutics, Inc.
|
150 Thousand USD
|
-483.467%
|
IXICO plc
|
275 Thousand USD
|
-218.255%
|
IntelGenx Technologies Corp.
|
11.83 Million USD
|
92.607%
|
Gelesis Holdings, Inc.
|
26.3 Million USD
|
96.673%
|
CSL Limited
|
11.23 Billion USD
|
99.992%
|
Cellectis S.A.
|
36.21 Million USD
|
97.583%
|